In this episode, we talk to Dylan Reid. He is a partner at Zetta Venture Partners, the first VC firm exclusively focused on identifying and supporting AI-driven, B2B businesses in critical domains like biotechnology, climate technology, DevOps and cloud infrastructure, security, and more.
Dive into Dylan’s thoughts on the convergence of AI, biology, and business, understanding the evolution and future prospects of AI startups. He reflects on Zetta's dedication to fostering AI solutions, emphasizing the importance of practical AI applications in advancing biology and healthcare.
Subscribe to Zypsy Spotlight wherever you listen to podcasts to learn more useful insights on what the future of venture capital looks like.
Links & resources
Dylan’s LinkedIn and Twitter
Zetta Ventures website, LinkedIn, and Twitter
Timestamp
00:00 Introduction
01:00 Dylan’s journey
03:27 LLMs and biological data
05:54 Advancement of technology
09:55 Finding and interacting with biotech founders
13:47 The power and promise of data in drug discovery
20:24 The world of research investments and potential breakthroughs
In this episode, we talk to Dylan Reid. He is a partner at Zetta Venture Partners, the first VC firm exclusively focused on identifying and supporting AI-driven, B2B businesses in critical domains like biotechnology, climate technology, DevOps and cloud infrastructure, security, and more.
Dive into Dylan’s thoughts on the convergence of AI, biology, and business, understanding the evolution and future prospects of AI startups. He reflects on Zetta's dedication to fostering AI solutions, emphasizing the importance of practical AI applications in advancing biology and healthcare.
Subscribe to Zypsy Spotlight wherever you listen to podcasts to learn more useful insights on what the future of venture capital looks like.
Links & resources
Dylan’s LinkedIn and Twitter
Zetta Ventures website, LinkedIn, and Twitter
Timestamp
00:00 Introduction
01:00 Dylan’s journey
03:27 LLMs and biological data
05:54 Advancement of technology
09:55 Finding and interacting with biotech founders
13:47 The power and promise of data in drug discovery
20:24 The world of research investments and potential breakthroughs